MELANOMA diagnostic service MoleMap plans to use its AI algorithim to help screen patients in the early stages of melanoma, rolling the technology out to its 50 clinics in New Zealand and potentially its Australian sites.
The above article was sent to subscribers in Pharmacy Daily's issue from 31 Jan 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Jan 23